![Jörg Blumentrath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Jörg Blumentrath worked as a Portfolio Manager & Healthcare Analyst at Medical Strategy GmbH from 2017 to 2020.
Former positions of Jörg Blumentrath
| Companies | Position | End |
|---|---|---|
Medical Strategy GmbH
 Medical Strategy GmbH Investment ManagersFinance MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health. MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research | Analyst-Equity | 31/01/2020 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Medical Strategy GmbH
Medical Strategy GmbH Investment ManagersFinance MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health. MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research | Finance |
- Stock Market
- Insiders
- Jörg Blumentrath
Choose MarketScreener 
